BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zopf S, Kremer AE, Neurath MF, Siebler J. Advances in hepatitis C therapy: What is the current state - what come’s next? World J Hepatol 2016; 8(3): 139-147 [PMID: 26839638 DOI: 10.4254/wjh.v8.i3.139]
URL: https://www.wjgnet.com/1948-5182/full/v8/i3/139.htm
Number Citing Articles
1
C. Nelson Hayes, Kazuaki Chayama. Interferon stimulated genes and innate immune activation following infection with hepatitis B and C virusesJournal of Medical Virology 2017; 89(3): 388 doi: 10.1002/jmv.24659
2
Reza Taherkhani, Fatemeh Farshadpour. Lurking epidemic of hepatitis C virus infection in Iran: A call to actionWorld Journal of Hepatology 2017; 9(24): 1040-1042 doi: 10.4254/wjh.v9.i24.1040
3
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationJournal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
4
Allison M. Bell, Jamie L. Wagner, Katie E. Barber, Kayla R. Stover. Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis CInternational Journal of Hepatology 2016; 2016: 1 doi: 10.1155/2016/3852126
5
Ilaria Izzo, Paola Zanotti, Claudia Chirico, Salvatore Casari, Vincenzo Villanacci, Marianna Salemme, Luciano Biasi, Elena Festa, Francesco Castelli. Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis CInfection 2016; 44(6): 811 doi: 10.1007/s15010-016-0915-x
6
Alice Sanna, Yann Le Strat, Françoise Roudot-Thoraval, Sylvie Deuffic Burban, Patrizia Carrieri, Elisabeth Delarocque-Astagneau, Christine Larsen. Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014 Eurosurveillance 2017; 22(30) doi: 10.2807/1560-7917.ES.2017.22.30.30582
7
Edward Tam, Julie Tremblay, Chris Fraser, Brian Conway, Alnoor Ramji, Sergio Borgia, Keith Tsoi, Eric M Yoshida, Bahe Rajendran, Gisela Macphail, Alexander Wong, Curtis Cooper, Keyur Patel, Marco Puglia, Kris Stewart, Benoit Trottier, Lucie Deshaies, Karen Doucette, Peter Ghali, Samuel S Lee, Jodi Halsey-Brandt, Janie B Trepanier. The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis CCanadian Liver Journal 2020; 3(3): 251 doi: 10.3138/canlivj-2019-0029
8
Hong-Tao Xu, Said A. Hassounah, Susan P. Colby-Germinario, Maureen Oliveira, Clare Fogarty, Yudong Quan, Yingshan Han, Olga Golubkov, Ilinca Ibanescu, Bluma Brenner, Brent R. Stranix, Mark A. Wainberg. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitorsJournal of Antimicrobial Chemotherapy 2017; : dkw514 doi: 10.1093/jac/dkw514
9
Suzanne JF Kaptein, Johan Neyts. Towards antiviral therapies for treating dengue virus infectionsCurrent Opinion in Pharmacology 2016; 30: 1 doi: 10.1016/j.coph.2016.06.002
10
Gislaine Silveira Olm. Dermatology in Public Health Environments2018; : 823 doi: 10.1007/978-3-319-33919-1_40
11
Tomoko Tadokoro, Asahiro Morishita, Kyoko Oura, Koji Fujita, Shima Mimura, Teppei Sakamoto, Takako Nomura, Joji Tani, Hirohito Yoneyama, Tsutomu Masaki. Grazoprevir/elbasvir treatment for the relapse of HCV genotype 1b infection after ledipasvir/sofosbuvir: A case reportExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6207
12
Maggie Phillips, Jumana Abboud, Bukola Abodunde, David P. Paul, Alberto Coustasse. The Growing Problem of Hepatitis C Virus InfectionThe Health Care Manager 2020; 39(1): 2 doi: 10.1097/HCM.0000000000000278
13
Charles B Nguyen, Courtney W Houchen, Naushad Ali. APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseasesExperimental Biology and Medicine 2017; 242(3): 242 doi: 10.1177/1535370216672746
14
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statementAutoimmunity Reviews 2016; 15(12): 1145 doi: 10.1016/j.autrev.2016.09.006
15
Experimental and Clinical Transplantation 2017; 15(6) doi: 10.6002/ect.2017.0104
16
Sarah Bauerle Bass, Amy Jessop, Laurie Maurer, Muhamed Gashat, Mohammed Al Hajji, Mercedes Gutierrez. Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention DevelopmentJournal of Health Communication 2018; 23(1): 117 doi: 10.1080/10810730.2017.1414902
17
J. E. Yap, P. Jaiswal, L. Ton, R. Szynkarek, B. M. Attar, S. Gandhi. Successful treatment of chronic hepatitis C infection with crushed elbasvir/grazoprevir administered via a percutaneous endoscopic gastrostomy tubeJournal of Clinical Pharmacy and Therapeutics 2018; 43(5): 730 doi: 10.1111/jcpt.12713
18
Núria Esforzado, José María Morales. Hepatitis C y trasplante renal: el tiempo de la erradicación del virus ha llegadoNefrología 2019; 39(5): 458 doi: 10.1016/j.nefro.2019.01.002
19
Núria Esforzado, José María Morales. Hepatitis C and kidney transplant: The eradication time of the virus has arrivedNefrología (English Edition) 2019; 39(5): 458 doi: 10.1016/j.nefroe.2019.01.009
20
Veronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, Maryam Bigdeli, Cornelis De Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo1O, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross-Degnan, Peter N Stephens, Yot Teerawattananon, Ellen ‘t Hoen, Anita K Wagner, Prashant Yadav, Michael R Reich. Essential medicines for universal health coverageKazan medical journal 2019; 100(1): 4 doi: 10.17816/KMJ2019-4
21
Yash Mittal, AnnMarie Liapakis, Joseph K. Lim. Treatment of chronic hepatitis C virus infection in patients with end-stage renal disease on hemodialysisClinical Liver Disease 2016; 8(3): 76 doi: 10.1002/cld.575
22
Matteo Castelli, Nicola Clementi, Jennifer Pfaff, Giuseppe A. Sautto, Roberta A. Diotti, Roberto Burioni, Benjamin J. Doranz, Matteo Dal Peraro, Massimo Clementi, Nicasio Mancini. A Biologically-validated HCV E1E2 Heterodimer Structural ModelScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00320-7
23
Sebastián Marciano, Leila Haddad, Fernando Plazzotta, Ezequiel Mauro, Sergio Terraza, Sanjeev Arora, Karla Thornton, Beatriz Ríos, Carlos García Dans, Natalia Ratusnu, Liliana Calanni, José Allevato, María Ester Sirotinsky, Marcos Pedrosa, Adrián Gadano. Implementation of the ECHO ® telementoring model for the treatment of patients with hepatitis C Journal of Medical Virology 2017; 89(4): 660 doi: 10.1002/jmv.24668
24
F Volpin, J Casaos, J Sesen, A Mangraviti, J Choi, N Gorelick, J Frikeche, T Lott, R Felder, S J Scotland, T S K Eisinger-Mathason, H Brem, B Tyler, N Skuli. Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeuticOncogene 2017; 36(21): 3037 doi: 10.1038/onc.2016.457
25
Harry Chown. A comparison of machine learning algorithms for the prediction of Hepatitis C NS3 protease cleavage sitesThe EuroBiotech Journal 2019; 3(4): 167 doi: 10.2478/ebtj-2019-0020
26
Andreza Soriano Figueiredo, Elisabeth Lampe, Pedro Pereira Lira Furtado de Albuquerque, Flávia Löwen Levy Chalhoub, Ana Maria Bispo de Filippis, Livia Melo Villar, Oswaldo Gonçalves Cruz, Marcelo Alves Pinto, Jaqueline Mendes de Oliveira. Epidemiological investigation and analysis of the NS5B gene and protein variability of non-primate hepacivirus in several horse cohorts in Rio de Janeiro state, BrazilInfection, Genetics and Evolution 2018; 59: 38 doi: 10.1016/j.meegid.2018.01.017
27
Yvonne Chasser, Arthur Y. Kim, Oliver Freudenreich. Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon EraPsychosomatics 2017; 58(1): 1 doi: 10.1016/j.psym.2016.09.004
28
Wataru Ito, Masaaki Toyama, Mika Okamoto, Masanori Ikeda, Koichi Watashi, Takaji Wakita, Yuichi Hashimoto, Masanori Baba. Isolation and characterization of hepatitis C virus resistant to a novel phenanthridinone derivativeAntiviral Chemistry and Chemotherapy 2015; 24(5-6): 148 doi: 10.1177/2040206616663956
29
Babita Agrawal, Rakesh Kumar. Symbiotic chemo- and immuno-therapy for hepatitis B and C virusesWorld Journal of Gastroenterology 2016; 22(25): 5623-5626 doi: 10.3748/wjg.v22.i25.5623
30
Julia M. Grottenthaler, Christoph R. Werner, Martina Steurer, Ulrich Spengler, Thomas Berg, Cornelius Engelmann, Heiner Wedemeyer, Thomas von Hahn, Wolfgang Stremmel, Anita Pathil, Ulrich Seybold, Eckart Schott, Usha Blessin, Christoph Sarrazin, Martin-Walter Welker, Ellen Harrer, Stefan Scholten, Clemens Hinterleitner, Ulrich M. Lauer, Nisar P. Malek, Christoph P. Berg, Chen-Hua Liu. Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantationPLOS ONE 2018; 13(6): e0197544 doi: 10.1371/journal.pone.0197544
31
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract2020;  doi: 10.1017/9781316823026
32
Claudia Minosse, Emanuela Giombini, Barbara Bartolini, Maria Capobianchi, Anna Garbuglia. Ultra-Deep Sequencing Characterization of HCV Samples with Equivocal Typing Results Determined with a Commercial AssayInternational Journal of Molecular Sciences 2016; 17(10): 1679 doi: 10.3390/ijms17101679
33
Amy B. Jessop, Sarah Bauerle Bass, Jesse Brajuha, Mohammed Alhajji, Monika Burke, Muhamed Tahar Gashat, Carine Wellington, Nicole Ventriglia, Jennie Coleman, Paul D'Avanzo. “Take Charge, Get Cured”: Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacyJournal of Substance Abuse Treatment 2020; 109: 23 doi: 10.1016/j.jsat.2019.11.001
34
Theogene Twagirumugabe, Gatare Swaibu, Tomas Bergström, Timothy David Walker, Jean Bosco Gahutu, Heléne Norder. Low prevalence of hepatitis C virus RNA in blood donors with anti‐hepatitis C virus reactivity in RwandaTransfusion 2017; 57(10): 2420 doi: 10.1111/trf.14204
35
Maliha Naseer, Harleen Chela, Alhareth AlJuboori. Viral Hepatitis: Chronic Hepatitis C2019; : 25 doi: 10.1007/978-3-030-03757-4_2
36
Giada Sebastiani, Nicole Wilkinson, Kostas Pantopoulos. Pharmacological Targeting of the Hepcidin/Ferroportin AxisFrontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00160
37
Sylvie Lagaye, Sonia Brun, Jesintha Gaston, Hong Shen, Ruzena Stranska, Claire Camus, Clarisse Dubray, Géraldine Rousseau, Pierre-Philippe Massault, Jerôme Courcambeck, Firas Bassisi, Philippe Halfon, Stanislas Pol. Anti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices modelWorld Journal of Hepatology 2016; 8(21): 902-914 doi: 10.4254/wjh.v8.i21.902
38
Guglielmo Borgia, Alberto Enrico Maraolo, Salvatore Nappa, Ivan Gentile, Antonio Riccardo Buonomo. NS5B polymerase inhibitors in phase II clinical trials for HCV infectionExpert Opinion on Investigational Drugs 2018; 27(3): 243 doi: 10.1080/13543784.2018.1420780
39
Nowlan Selvapatt, Ashley Brown. A real-world intention-to-treat analysis of a decade’s experience of treatment of hepatitis C with interferon-based therapiesF1000Research 2016; 5: 2061 doi: 10.12688/f1000research.9114.1
40
Steffen Zopf, Lara Rösch, Peter C. Konturek, Ruediger S. Goertz, Markus F. Neurath, Deike Strobel. Low Pretreatment Acoustic Radiation Force Impulse Imaging (ARFI) Values Predict Sustained Virological Response in Antiviral Hepatitis C Virus (HCV) TherapyMedical Science Monitor 2016; 22: 3500 doi: 10.12659/MSM.896344
41
Sarah Bauerle Bass, Amy Jessop, Muhamed Gashat, Laurie Maurer, Mohammed Alhajji, Jon Forry. Take Charge, Get Cured: The development and user testing of a culturally targeted mHealth decision tool on HCV treatment initiation for methadone patientsPatient Education and Counseling 2018; 101(11): 1995 doi: 10.1016/j.pec.2018.07.007
42
Aoife McCarthy, Kieran Sheahan. Non-Neoplastic Pathology of the Gastrointestinal Tract2020; : 65 doi: 10.1017/9781316823026.006
43
Aldo Bonaventura, Fabrizio Montecucco. Sofosbuvir/velpatasvir: A promising combinationWorld Journal of Hepatology 2016; 8(19): 785-789 doi: 10.4254/wjh.v8.i19.785
44
Nagraj Mani, Andrew G. Cole, Janet R. Phelps, Andrzej Ardzinski, Kyle D. Cobarrubias, Andrea Cuconati, Bruce D. Dorsey, Ellen Evangelista, Kristi Fan, Fang Guo, Haitao Guo, Ju-Tao Guo, Troy O. Harasym, Salam Kadhim, Steven G. Kultgen, Amy C. H. Lee, Alice H. L. Li, Quanxin Long, Sara A. Majeski, Richeng Mao, Kevin D. McClintock, Stephen P. Reid, Rene Rijnbrand, Nicholas M. Snead, Holly M. Micolochick Steuer, Kim Stever, Sunny Tang, Xiaohe Wang, Qiong Zhao, Michael J. Sofia. Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA EncapsidationAntimicrobial Agents and Chemotherapy 2018; 62(6) doi: 10.1128/AAC.00082-18
45
Veronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, Maryam Bigdeli, Cornelis P de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross-Degnan, Peter N Stephens, Yot Teerawattananon, Ellen F M 't Hoen, Anita K Wagner, Prashant Yadav, Michael R Reich. Essential medicines for universal health coverageThe Lancet 2017; 389(10067): 403 doi: 10.1016/S0140-6736(16)31599-9
46
Mark R. Schleiss, Ketzela J. Marsh. Avery's Diseases of the Newborn2018; : 482 doi: 10.1016/B978-0-323-40139-5.00037-1
47
L. Couronné, E. Bachy, S. Roulland, B. Nadel, F. Davi, M. Armand, D. Canioni, J.M. Michot, C. Visco, L. Arcaini, C. Besson, O. Hermine. From hepatitis C virus infection to B-cell lymphomaAnnals of Oncology 2018; 29(1): 92 doi: 10.1093/annonc/mdx635
48
Tarik Asselah, Stefan Bourgeois, Stephen Pianko, Stefan Zeuzem, Mark Sulkowski, Graham R. Foster, Lingling Han, John McNally, Anu Osinusi, Diana M. Brainard, G. Mani Subramanian, Edward J. Gane, Jordan J. Feld, Alessandra Mangia. Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosisLiver International 2018; 38(3): 443 doi: 10.1111/liv.13534